SciSparc Ltd. (NASDAQ:SPRC) Sees Significant Drop in Short Interest

SciSparc Ltd. (NASDAQ:SPRC) was the recipient of a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 609,200 shares, a decrease of 40.9% from the March 15th total of 1,030,000 shares. Based on an average daily trading volume, of 5,690,000 shares, the days-to-cover ratio is currently 0.1 days. Currently, 5.6% of the shares of the company are sold short.

SciSparc Stock Down 6.0 %

Shares of NASDAQ SPRC opened at $0.27 on Thursday. SciSparc has a 1-year low of $0.20 and a 1-year high of $1.79. The business’s fifty day moving average price is $0.36 and its two-hundred day moving average price is $0.35.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.